Paper Details 
Original Abstract of the Article :
Budesonide inhalation powder, available as Pulmicort Turbuhaler, is a corticosteroid with a high ratio of local to systemic effects that is administered to treat persistent asthma. The Turbuhaler achieves lung deposition approximately twice that of a metered-dose inhaler (MDI) with or without a spac...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/9692646

データ提供:米国国立医学図書館(NLM)

Budesonide Inhalation Powder: A Breath of Fresh Air for Asthma Patients

Budesonide inhalation powder is a widely used corticosteroid medication for treating persistent asthma. This review examines the pharmacologic properties of budesonide inhalation powder and its role in asthma management. Budesonide is a highly effective anti-inflammatory agent that reduces airway inflammation and improves lung function. It is delivered via the Turbuhaler, a convenient and user-friendly device that achieves lung deposition approximately twice that of a metered-dose inhaler (MDI). The review highlights the clinical efficacy of budesonide, equivalent to that of other inhaled corticosteroids, with a favorable safety profile. Budesonide has lower systemic bioavailability than other inhaled corticosteroids, leading to fewer systemic side effects. The most common side effects are dysphonia, a change in voice, and oral candidiasis, a yeast infection of the mouth.

A Powerful Tool for Asthma Management

Budesonide inhalation powder has emerged as a valuable tool in the treatment of asthma, offering a balance between efficacy and safety. Its convenient delivery via the Turbuhaler and its reduced systemic side effects make it a popular choice for asthma patients. The review emphasizes the importance of individualized dosing, with the starting dose typically ranging from 200 microg to 800 microg twice a day, depending on the severity of asthma.

Breathing Easier with Budesonide

For asthma patients, budesonide inhalation powder can be a breath of fresh air, offering relief from the symptoms and improving their overall quality of life. The ability to control airway inflammation and improve lung function allows patients to participate more fully in daily activities, reducing the burden of their condition. However, it’s essential to remember that budesonide is not a cure for asthma, and continued monitoring and management are essential for long-term control of the disease.

Dr. Camel's Conclusion

This review reminds us that the desert of asthma management is not devoid of effective treatments. Budesonide inhalation powder provides a powerful tool for controlling airway inflammation and improving lung function, offering a glimmer of hope to those living with this chronic condition.

Date :
  1. Date Completed 1998-10-07
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

9692646

DOI: Digital Object Identifier

9692646

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.